Agalimmune Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agalimmune ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agalimmune Ltd Today - Breaking & Trending Today

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced results from. ....

United States , United Kingdom , Moran Meir , John Lacey , Philip Serlin , Prnewswire Biolinerx Ltd , Lifesci Advisors , Exchange Commission On , Biolinerx Ltd , Agalimmune Ltd , Study Met Primary Endpoint , Seek Publication , Complete Data Analysis , Chief Executive Officer , Tumor Cancer Type , Squamous Cell , Cervical Node , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors , Biolinerx Ltd ,

BioLineRx : Annual Report by Foreign Issuer (Form 20-F)

A >5-fold increase. The addition of motixafortide to G-CSF also allowed 88.3% of patients to undergo transplantation after only one apheresis session, compared to 10.8% in the G-CSF arm - an. | March 16, 2022 ....

United States , United Kingdom , Kode Biotech , Biokine Therapeutics Ltd , Drug Administration , Agalimmune Development Agreement , Agalimmune Ltd , University Of Massachusetts , European Union , Innovative Pharmaceutical Concepts Inc , Risks Related , Regulatory Matters , New Drug Application , Kode Biotech Limited , Innovative Pharmaceutical Concepts , Licensing Agreements , Agalimmune Development , Annual Report , Quality System Regulations , Biolinerx Ltd Stock Exchange , Press Release , Rm Blrx Il0011015182 ,

BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, AGI-134, in Unresectable Metastatic Solid Tumors

/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced that the. ....

United States , United Kingdom , Moran Meir , Philip Serlin , Tim Mccarthy , Prnewswire Biolinerx Ltd , Lifesci Advisors , Exchange Commission On , Biolinerx Ltd , Agalimmune Ltd , Chief Executive Officer , Immuno Oncology Scientific Advisory Board , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors , Biolinerx Ltd ,

Notice of annual general meeting in Cantargia AB (publ)

Notice of annual general meeting in Cantargia AB (publ)
STOCKHOLM, April 27, 2021 /PRNewswire/
The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Wednesday, 26 May 2021. In light of the corona virus, the meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend the meeting in person or by proxy.
Notification of participation, etc.
A shareholder who would like to participate in the meeting must (i) be entered in the register of shareholders maintained by Euroclear Sweden AB by Tuesday, 18 May 2021, and (ii) announce their participation no later than Tuesday, 25 May 2021, by having submitted an advance voting form in accordance with the instructions in the section Advance voting below such that the company has received the advance vote no later than this date. ....

United Kingdom , Uppsala Lan , Anders Martin , Magnus Nilsson , Flavia Borellini , Karin Leandersson , Mikael Wiberg Alecta Pensionsf , Resolys Bio , Thoas Fioretos , Karo Bio , Marianne Nilsson Swedbank , Damian Marron , Magnus Persson , Claus Asbj , Patricia Delaite , Uppsala University , Swedish Companies Registration Office Sw , Cytoseek Ltd , Jannis Kitsakis Fourth Swedish National Pension Fund , Employee Option Program , University Of Liverpool , Agalimmune Ltd , Head Of European Business Development , M Health Care , Imophoron Ltd , A Implementation Of Employee Option Program ,